385 related articles for article (PubMed ID: 18782107)
1. Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications.
Derendorf H; Meltzer EO
Allergy; 2008 Oct; 63(10):1292-300. PubMed ID: 18782107
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of intranasal corticosteroids.
Szefler SJ
J Allergy Clin Immunol; 2001 Jul; 108(1 Suppl):S26-31. PubMed ID: 11449203
[TBL] [Abstract][Full Text] [Related]
3. Mometasone furoate. A review of its intranasal use in allergic rhinitis.
Onrust SV; Lamb HM
Drugs; 1998 Oct; 56(4):725-45. PubMed ID: 9806113
[TBL] [Abstract][Full Text] [Related]
4. A review of the preclinical and clinical data of newer intranasal steroids used in the treatment of allergic rhinitis.
Lumry WR
J Allergy Clin Immunol; 1999 Oct; 104(4 Pt 1):S150-8. PubMed ID: 10518812
[TBL] [Abstract][Full Text] [Related]
5. A 2-week, crossover study to investigate the effect of fluticasone furoate nasal spray on short-term growth in children with allergic rhinitis.
Gradman J; Caldwell MF; Wolthers OD
Clin Ther; 2007 Aug; 29(8):1738-47. PubMed ID: 17919555
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic/pharmacodynamic profile of mometasone furoate nasal spray: potential effects on clinical safety and efficacy.
Hochhaus G
Clin Ther; 2008 Jan; 30(1):1-13. PubMed ID: 18343239
[TBL] [Abstract][Full Text] [Related]
7. Safety update regarding intranasal corticosteroids for the treatment of allergic rhinitis.
Blaiss MS
Allergy Asthma Proc; 2011; 32(6):413-8. PubMed ID: 22221434
[TBL] [Abstract][Full Text] [Related]
8. Long-term safety of fluticasone furoate nasal spray in adults and adolescents with perennial allergic rhinitis.
Rosenblut A; Bardin PG; Muller B; Faris MA; Wu WW; Caldwell MF; Fokkens WJ
Allergy; 2007 Sep; 62(9):1071-7. PubMed ID: 17686110
[TBL] [Abstract][Full Text] [Related]
9. A review of the pharmacology and pharmacokinetics of inhaled fluticasone propionate and mometasone furoate.
Crim C; Pierre LN; Daley-Yates PT
Clin Ther; 2001 Sep; 23(9):1339-54. PubMed ID: 11589253
[TBL] [Abstract][Full Text] [Related]
10. Intranasal corticosteroids for allergic rhinitis.
Trangsrud AJ; Whitaker AL; Small RE
Pharmacotherapy; 2002 Nov; 22(11):1458-67. PubMed ID: 12432972
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of patients' preferences for triamcinolone acetonide aqueous, fluticasone propionate, and mometasone furoate nasal sprays in patients with allergic rhinitis.
Stokes M; Amorosi SL; Thompson D; Dupclay L; Garcia J; Georges G
Otolaryngol Head Neck Surg; 2004 Sep; 131(3):225-31. PubMed ID: 15365540
[TBL] [Abstract][Full Text] [Related]
12. Intranasal corticosteroids and adrenal suppression.
Bruni FM; De Luca G; Venturoli V; Boner AL
Neuroimmunomodulation; 2009; 16(5):353-62. PubMed ID: 19571596
[TBL] [Abstract][Full Text] [Related]
13. Assessment of sensory perceptions and patient preference for intranasal corticosteroid sprays in allergic rhinitis.
Khanna P; Shah A
Am J Rhinol; 2005; 19(3):316-21. PubMed ID: 16011141
[TBL] [Abstract][Full Text] [Related]
14. Fluticasone furoate: a new intranasal corticosteroid.
Kumar R; Kumar D; Parakh A
J Postgrad Med; 2012; 58(1):79-83. PubMed ID: 22387656
[TBL] [Abstract][Full Text] [Related]
15. Reader's response to "comparison of once-daily intranasal corticosteroids for the treatment of allergic rhinitis: are they all the same?".
Philpot EE
MedGenMed; 2006 Apr; 8(2):3; author reply 2. PubMed ID: 16926742
[No Abstract] [Full Text] [Related]
16. Influence of treatment with intranasal corticosteroids on the nasal mucosa, weight, and corticosteroid concentration in rats.
Park DM; Carvalho TL; Franci JA; Anselmo-Lima WT
Am J Rhinol Allergy; 2012; 26(1):e46-9. PubMed ID: 22182666
[TBL] [Abstract][Full Text] [Related]
17. Safety of intranasal corticosteroids in acute rhinosinusitis.
Demoly P
Am J Otolaryngol; 2008; 29(6):403-13. PubMed ID: 19144302
[TBL] [Abstract][Full Text] [Related]
18. Intranasal corticosteroids: the development of a drug delivery device for fluticasone furoate as a potential step toward improved compliance.
Berger WE; Godfrey JW; Slater AL
Expert Opin Drug Deliv; 2007 Nov; 4(6):689-701. PubMed ID: 17970670
[TBL] [Abstract][Full Text] [Related]
19. Systemic effects of intranasal steroids: an endocrinologist's perspective.
Allen DB
J Allergy Clin Immunol; 2000 Oct; 106(4 Suppl):S179-90. PubMed ID: 11032642
[TBL] [Abstract][Full Text] [Related]
20. Nasal allergies and beyond: a clinical review of the pharmacology, efficacy, and safety of mometasone furoate.
van Drunen C; Meltzer EO; Bachert C; Bousquet J; Fokkens WJ
Allergy; 2005; 60 Suppl 80():5-19. PubMed ID: 15948774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
